Initial models included age (greater than 50), surgery, left or right breast, smoking status, collagen vascular disease, axillary dissection, tumor grade, pathologic T stage, estrogen receptor status, progesterone receptor status, Her2neu receptor status, and adjuvant hormone therapy treatment. This evidence concerns the gene ESR1 and neoplasm.